What question did this study set out to answer?

The study aims to investigate the relationship between serum FABP4 and liver and kidney health in thalassemia patients.

March 25, 2026Open Access

Elevated Fatty Acid Binding Protein 4 (FABP4) Associated With Liver Damage and Kidney Complications in Thalassemia Patients

Key Points

The study aims to investigate the relationship between serum FABP4 and liver and kidney health in thalassemia patients.
Analyzed serum levels of FABP4, bilirubin, and AST/ALT in thalassemia patients
Investigated correlations between serum FABP4 and liver injury markers
Assessed kidney complications in relation to serum FABP4 levels
Serum FABP4 levels significantly differed in relation to bilirubin and AST/ALT ratios
A connection was found between elevated FABP4 and indicators of liver injury
Kidney complications showed correlation with higher serum FABP4 levels

Abstract

A significant difference was seen between serum FABP4 and bilirubin and AST/ALT ratio, showing a connection between serum FABP4 and liver injury and kidney complications. Consequently, while further studies are essential for a comprehensive exploration of this hypothesis, serum FABP4 may have a potential role in chronic diseases in thalassemia patients.

Elevated Fatty Acid Binding Protein 4 (FABP4) Associated With Liver Damage and Kidney Complications in Thalassemia Patients

Key Points

Abstract

Cite This Study